InphA elaborates monographs for International Pharmacopoeia

At its annual meeting the Expert Committee of the International Pharmacopoeia (Ph. Int.) has adopted two monographs which were revised/elaborated in collaboration with InphA GmbH making them available to users of Ph. Int. worldwide.

The two monographs are Dexamethasone Sodium Phosphate (active ingredient) and  Dexamethasone Phosphate Injection, where the first one had to be revised and the second one was a new monograph to the Ph. Int. In this new monograph a new impurity that can be formed in certain preparations has been described and limited for the first time in a pharmacopoeia.

Medicines containing Dexamethasone are on the WHO Model list of essential medicines. They play an inportant role in preventing premature birth complications.